Valuation Amgen Inc.

Stocks

Market Closed - Nasdaq 01:30:00 02/10/2026 am IST			5-day change	1st Jan Change
407.27 ^USD	-3.38%		+0.30%	+24.43%

30/09	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
28/09	Scotiabank Raises Amgen Price Target to $500 From $450, Sector Outperform Rating Kept	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,26,718	1,40,139	1,54,142	1,40,103	1,76,250	2,20,183	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	24.93%	-	-
Enterprise Value (EV) ¹	1,51,990	1,69,779	2,07,811	1,88,229	2,21,725	2,61,669	2,56,000	2,50,997
Change	-	11.7%	22.4%	-9.42%	17.8%	18.01%	-2.17%	-1.95%
P/E	21.9x	21.7x	23.1x	34.5x	23x	25.7x	23x	22.1x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	19.5x	15.9x	12.8x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.3x	2x	5.33x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.65x	5.46x	5.29x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.72x	6.35x	6.03x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	12x	11.5x	11.2x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	15.4x	14.5x	13.6x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	23.5x	17.4x	16.3x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	4.25%	5.76%	6.13%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.48%	2.62%	2.73%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.83	17.67	18.41
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	63.7%	60.3%	60.4%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,938	40,309	41,654
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,864	22,213	22,322
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,964	17,686	18,396
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,581	9,393	9,971
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,485	35,817	30,814
Reference price ²	224.97	262.64	288.02	260.64	327.31	407.27	407.27	407.27
Nbr of stocks (in thousands)	5,63,266	5,33,579	5,35,178	5,37,533	5,38,481	5,40,632	-	-
Announcement Date	07/02/22	31/01/23	06/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AMGEN INC.	26.62x	6.92x	12.32x	2.39%	23TCr
ELI LILLY AND COMPANY	32.9x	11.93x	24.23x	0.6%	1,03100Cr
JOHNSON & JOHNSON	29.45x	6.54x	18.31x	2.02%	64TCr
ABBVIE INC.	33.1x	7.75x	16.02x	2.65%	46TCr
MERCK & CO., INC.	105.72x	5.91x	25.05x	2.35%	36TCr
ROCHE HOLDING AG	19x	4.63x	11.48x	2.87%	33TCr
NOVARTIS AG	20.37x	5.28x	13.08x	3.03%	27TCr
ASTRAZENECA PLC	20.79x	4.31x	12.28x	2.05%	25TCr
GILEAD SCIENCES, INC.	-45.08x	6.57x	25.65x	2.21%	18TCr
NOVO NORDISK A/S	11.34x	4.12x	8.57x	4.43%	17TCr
Average	25.42x	6.40x	16.70x	2.46%	39.34TCr
Weighted average by Cap.	31.21x	7.56x	18.45x	2.03%